24.2 C
New York
Thursday, June 11, 2026

Tag: Science and Technology

newssourceFORcompanyinformationcontent1marketreleases

“HYAB Thematic Youth Internship Programmes to the Mainland – Youth Internship Programme at Dunhuang 2025” Achieves Remarkable Results

Exploring the Treasures of the Thousand-Year Silk Road  Starting a New Chapter in the Heritage of Dunhuang Culture HONG KONG, July 30, 2025 /PRNewswire/ -- The...

Future is Bright for Academic Partnership Program at Canada’s National Nuclear Laboratory as Universities Agree to Five-Year Extensions

Innovative academic program contributes to a strong and sustainable talent pipeline for Canada’s national nuclear laboratories and Canadian nuclear sector 
Innovative academic program contributes to a strong and sustainable talent pipeline for Canada’s national nuclear laboratories and Canadian nuclear sector

FluoSolv® 5408 Approved For Use Under Boeing Spec BAC 5408

EMERYVILLE, Calif., July 29, 2025 /PRNewswire/ -- NuGenTec, the manufacturer of FluoSolv® vapor-degreasing solvents, has now received approval for the use of FluoSolv 5408...

WuXi Biologics Singapore CRDMO Hub Advances with the Launch of Modular Drug Product Facility Fabrication

Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats.Finished building will be one of...

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

OMG! Probiotic Beer Celebrates SG60

SINGAPORE, July 25, 2025 /PRNewswire/ -- Welcome to the future of beer – where great taste meets gut health. Zesty Gut Pte Ltd and...

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

Canada Invests in Wildfire Innovation and Resilience Through New Centre of Excellence

OTTAWA, ON, July 18, 2025 /CNW/ - With wildfires impacting Canadians across the country, the federal government is taking action to prevent wildfires, mitigate...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – 
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

PolyU launches advanced education programme, offering short courses to keep learners abreast of sci-tech developments

HONG KONG, July 17, 2025 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) is committed to promoting interdisciplinary research to provide solutions to pressing...

World Youth Skills Day 2025: Shanghai Electric Champions AI and Digital Skills with Global Innovation Tournament

Inspiring young talents to pioneer innovations in green technology, advanced manufacturing, and digital intelligence SHANGHAI, July 16, 2025 /PRNewswire/ -- Shanghai Electric (SEHK: 2727, SSE:...

Chalk River Laboratories Becomes First GLP-Certified Laboratory in Canada to Offer Pre-Clinical Radiopharmaceutical Studies

Following successful SCC audit, CNL is ready to perform pre-clinical studies for growing radiopharmaceutical industry as GLP-compliant laboratory 
Following successful SCC audit, CNL is ready to perform pre-clinical studies for growing radiopharmaceutical industry as GLP-compliant laboratory

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

- A word from our sponsors -

spot_img
HomeTagsScience and Technology

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers